Curcumin-Based Nanomedicines as Cancer Therapeutics

— —

Amirhossein Sahebkar (Biotechnologist and Associate Professor of Medical Biotechnology, Mashhad University of Medical Sciences, Iran) Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)

Curcumin-Based Nanomedicines as Cancer Therapeutics

Amirhossein Sahebkar (Biotechnologist and Associate Professor of Medical Biotechnology, Mashhad University of Medical Sciences, Iran), Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)

$290.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
22 February 2024

Enterprise software

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries.

Nanocurcumin has been widely explored for the treatment of various cancers; however, the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts.

In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen, and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments.

Edited by: Amirhossein Sahebkar (Biotechnologist and Associate Professor of Medical Biotechnology Mashhad University of Medical Sciences Iran), Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 191mm,
Weight: 450g
ISBN: 9780443154126
ISBN 10: 0443154120
Pages: 490
Publication Date: 22 February 2024
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Part-A: Curcumin: Introduction, structure, and physicochemical attributes 1. Curcumin: historical background, introduction, structure, and physicochemical attributes 2. Curcumin as a pharmaceutical leader 3. Chemical structure and molecular targets of curcumin for cancer therapy 4. Structural features of curcumin and its effects on cancer-related signaling pathways 5. An overview of cellular, molecular, and biological aspect(s) of curcumin in cancer Part-B: Smart drug delivery approaches for curcumin delivery in cancer therapy 6. Curcumin-drug conjugate-based drug delivery as cancer therapeutics 7. Curcumin microcapsule-based drug delivery as cancer therapeutics Part-C: Recent advances and regulatory aspects of gold nanoparticles 8. Nanoemulsion-based curcumin delivery systems as cancer therapeutics 9. Micelle-based curcumin delivery systems as cancer therapeutics 10. Liposome-based curcumin delivery systems as cancer therapeutics 11. Inorganic nanoparticle-based curcumin delivery as cancer therapeutics 12. PLGA nanoparticle-based curcumin delivery as cancer therapeutics 13. Polymersomes-based curcumin delivery as cancer therapeutics Part-D: Recent advances in nanocurcumin delivery in cancer therapy 14. Biopolymer-based formulations for curcumin delivery toward cancer management 15. Nanohybrid drug delivery approach as a novel opportunity for curcumin delivery in cancer 16. Codelivery of curcumin and siRNA as anticancer therapeutics Part-E: Challenges and future perspectives of nano-curcumin drug delivery 17. Challenges associated with nanocurcumin anticancer drug delivery systems 18. Curcumin-loaded nanoparticles used for in vivo cancer models: an approach about their physicochemical properties and mechanism of action 19. Clinical trials, patents, and marketed products of nanocurcumin-based anticancer drug delivery systems

Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids. Dr. Prashant Kesharwani is working as an assistant professor of pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 20 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also a receipt of several internationally acclaimed awards such as the most prestigious “Ramanujan Fellowship Award from the Science and Engineering Research Board, Government of India. He actively participates in outreach and scientific dissemination for the service of the wider community.

PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Curcumin-Based Nanomedicines as Cancer Therapeutics

Amirhossein Sahebkar (Biotechnologist and Associate Professor of Medical Biotechnology, Mashhad University of Medical Sciences, Iran), Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)

$290.95

Paperback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S